Nasivin Aloe Vera (Oxymetazoline Hydrochloride)

Oxymetazoline is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa it binds to alpha‑1 and alpha‑2 receptors on vascular smooth muscle, causing vasoconstriction. This reduces blood flow, decreases mucosal edema, and opens the airway for easier breathing.

The specific dose and frequency are determined by the prescribing healthcare professional or the product label. Typically, one or two sprays per nostril are used, but the exact regimen should follow the guidance of a qualified clinician.

Safety data for oxymetazoline in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using this product to weigh potential risks and benefits.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nasivin Aloe Vera contains oxymetazoline, a potent alpha‑adrenergic agonist that provides rapid relief with a relatively low dosing frequency. Compared with older agents such as phenylephrine, oxymetazoline often offers longer duration of action and less systemic absorption, but all topical decongestants share a risk of rebound congestion if used beyond recommended limits.

Store the nasal spray at temperatures below 25 °C (77 °F). Keep it in the original packaging, protect it from moisture, direct sunlight, and extreme heat. Do not freeze the product, and ensure the cap is tightly closed when not in use.

The spray is applied directly into each nostril while the head is upright. Gently insert the nozzle into the nostril, press the pump to deliver the recommended number of sprays, and then breathe normally. Avoid blowing the nose immediately after administration to allow the medication to act.

Serious risks include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, significant increases in blood pressure, tachycardia, and rare allergic reactions such as rash or anaphylaxis. Patients with cardiovascular disease should use the product with caution and seek medical advice if severe symptoms develop.

Individuals under six years of age, patients with known hypersensitivity to oxymetazoline or any formulation component, and those taking monoamine oxidase inhibitors or other potent sympathomimetics should avoid using this nasal spray unless directed by a healthcare professional.